Codex DNA, Inc. Contracts & Agreements
42 Contracts & Agreements
- Business Finance (18 contracts)
- Business Operations (5)
- Human Resources (14)
- Real Estate (2)
- Uncategorized (3)
- Offer Letter between the Company and William Kullback dated August 10, 2023 (Filed With SEC on August 29, 2023)
- Amendment No. 2 to Credit, Security and Guaranty Agreement (Term Loan) (Filed With SEC on August 11, 2023)
- Amendment No. 2 to Credit, Security and Guaranty Agreement (Revolving Loan) (Filed With SEC on August 11, 2023)
- Form of Warrant issued to an affiliate of H.C. Wainwright & Co., LLC (Filed With SEC on June 9, 2023)
- Form of Short-Term Warrant (Filed With SEC on May 31, 2023)
- Form of Long-Term Warrant (Filed With SEC on May 31, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on May 31, 2023)
- Redeemable Convertible Preferred Stock and Warrant Purchase Agreement dated May 31, 2023 (Filed With SEC on May 31, 2023)
- Form of Registration Rights Agreement (Filed With SEC on May 31, 2023)
- Amendment to Investors Rights Agreement dated May 31, 2023 (Filed With SEC on May 31, 2023)
- Confirmatory Offer Letter between the Company and Eric Esser dated May 2, 2022 (Filed With SEC on May 2, 2023)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on August 10, 2022)
- Separation Agreement and Release between the Registrant and Jennifer McNealey, dated June 22, 2022 (Filed With SEC on June 24, 2022)
- Research Collaboration and License Agreement by and between Registrant and Pfizer Inc. dated December 20, 2021 (Filed With SEC on March 23, 2022)
- Description of the Registrant's securities registered pursuant to section 12 of the securities exchange act of 1934 (Filed With SEC on March 23, 2022)
- Second Amendment to Loan and Security Agreement by and between Codex DNA, Inc. and Silicon Valley Bank, dated November 8, 2021 (Filed With SEC on November 10, 2021)
- Separation and General Release Agreement (Filed With SEC on November 10, 2021)
- Lease by and between the Registrant and BRE-BMR Wateridge Pointe LP dated September 29, 2021 (Filed With SEC on November 10, 2021)
- Share Purchase Agreement among Codex DNA, Inc. and the stockholders of Eton Bioscience Inc. dated November 9, 2021 (Filed With SEC on November 9, 2021)
- 2021 Stock Incentive Plan to be in effect upon the completion of this offering (Filed With SEC on June 14, 2021)
- Confidential Settlement Agreement between the Registrant and New England Biolabs, Inc. dated September 20, 2017 (Filed With SEC on June 14, 2021)
- Specimen common stock certificate of the Registrant (Filed With SEC on June 14, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 14, 2021)
- Warrant to Purchase Stock issued to Silicon Valley Bank, dated as of March 4, 2021 (Filed With SEC on May 28, 2021)
- Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated December 19, 2019 (Filed With SEC on May 28, 2021)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on May 28, 2021)
- 2019 Stock Plan, as amended, and forms of agreement thereunder (Filed With SEC on May 28, 2021)
- 2021 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on May 28, 2021)
- 2021 Stock Incentive Plan (Filed With SEC on May 28, 2021)
- 2021 Employee Stock Purchase Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on May 28, 2021)
- Confirmatory Employment Letter between the Registrant and Todd Nelson dated May 19, 2021 (Filed With SEC on May 28, 2021)
- Confirmatory Employment Letter between the Registrant and Jennifer McNealey dated May 19, 2021 (Filed With SEC on May 28, 2021)
- Confirmatory Employment Letter between the Registrant and Daniel Gibson dated May 19, 2021 (Filed With SEC on May 28, 2021)
- Confirmatory Employment Letter between the Registrant and Timothy Cloutier dated May 19, 2021 (Filed With SEC on May 28, 2021)
- Confirmatory Employment Letter between the Registrant and Brent Hunter dated May 19, 2021 (Filed With SEC on May 28, 2021)
- Executive Incentive Compensation Plan (Filed With SEC on May 28, 2021)
- Form of Change in Control Severance Agreement (Filed With SEC on May 28, 2021)
- Outside Director Compensation Policy (Filed With SEC on May 28, 2021)
- Office Lease, dated April 4, 2019, between the Registrant and BMR-Waples LP, as amended (Filed With SEC on May 28, 2021)
- Supply Agreement, dated October 26, 2015, between the Registrant and Integrated DNA Technologies, Inc., as amended (Filed With SEC on May 28, 2021)
- Loan and Security Agreement, dated March 4, 2021, between the Registrant and Silicon Valley Bank (Filed With SEC on May 28, 2021)
- Confidential Settlement Agreement between the Registrant and New England Biolabs, Inc. dated September 20, 2017 (Filed With SEC on May 28, 2021)